Gov. Tony Evers said Wisconsin would join a disease alert network led by the World Health Organization. A handful of other U.S. states have joined the network after President Donald Trump formally ...

The MAC is adding Sacramento State as a football-only member starting in 2026, the conference announced on Monday. The Hornets will join the conference on July 1 for a five-year term. Sac State will ...

Feb 15 (Reuters) - Peter Steinberger, the founder of OpenClaw, is joining OpenAI, and the open-source bot is becoming a foundation, OpenAI CEO Sam Altman said on Sunday. "Peter Steinberger is joining ...

New York City has joined a United Nations health network in the wake of the United States leaving the World Health Organization (WHO). In a press release Thursday, the New York City Department of ...

WASHINGTON, Feb 4 (Reuters) - The New York City Health Department on Wednesday said it has joined the World Health Organization's global outbreak response network following President Donald ‌Trump's ...

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

LEAST 115 PEOPLE SINCE SEPTEMBER. THE UNITED STATES HAS FORMALLY LEFT THE WORLD HEALTH ORGANIZATION. THE W.H.O. SAYS MEMBERS OF ITS EXECUTIVE BOARD WILL NOW TALK ABOUT HOW TO HANDLE THE U.S.

California Gov. Gavin Newsom (D) announced just one day after the U.S. officially withdrew from the World Health Organization (WHO) that his state would become the first to join the organization’s ...

Recursive language models (RLMs) are an inference technique developed by researchers at MIT CSAIL that treat long prompts as an external environment to the model. Instead of forcing the entire prompt ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Andres Almiray, a serial open-source ...

Recursion Pharmaceuticals' AI-based approach has the potential to transform the pharmaceutical industry. However, it is still chasing clinical wins that would demonstrate the power of its strategy.